Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Symptomatic trans-sexualism.

Commander M, Dean C.

Br J Psychiatry. 1990 Jun;156:894-6.

PMID:
2207525
2.

[Delusional "pseudotranssexualism" in schizophrenic psychosis].

Brüne M.

Psychiatr Prax. 1996 Sep;23(5):246-7. German.

PMID:
8992520
3.

Invitation to compliance. The Prolixin brunch.

Cassino T, Spellman N, Heiman J, Shupe J, Sklebar HT.

J Psychosoc Nurs Ment Health Serv. 1987 Oct;25(10):15-6, 19. No abstract available.

PMID:
3681773
4.
5.

Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.

Odejide OA, Aderounmu AF.

J Clin Psychiatry. 1982 May;43(5):195-6.

PMID:
7076630
6.

Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community.

Stevens BC.

Psychol Med. 1973 May;3(2):141-58. No abstract available.

PMID:
4577254
7.

Delusional "pseudotranssexualism" in schizophrenia.

Borras L, Huguelet P, Eytan A.

Psychiatry. 2007 Summer;70(2):175-9.

PMID:
17661542
8.

Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.

Gaby N, Lefkowitz D, Israel JR.

N C Med J. 1982 Sep;43(9):641-4. No abstract available.

PMID:
6958987
9.

Characteristics of schizophrenic patients and the outcome of fluphenazine and of electroconvulsive treatments.

Landmark J, Joseph L, Merskey H.

Can J Psychiatry. 1987 Aug;32(6):425-8.

PMID:
3690470
10.

[Gender identity disorders as a symptom of psychosis, schizophrenia in particular].

Campo JM, Nijman H, Evers C, Merckelbach HL, Decker I.

Ned Tijdschr Geneeskd. 2001 Sep 29;145(39):1876-80. Dutch.

PMID:
11605311
12.

Fluphenazine decanoate in acute and maintenance therapy of schizophrenia.

Altamura AC, Mauri MC, Guercetti G, Cazzullo CL.

Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(5):613-23.

PMID:
3122268
13.

[Flufenazine decanoate in the ambulatory treatment of schizophrenic patients].

Populin M, De Vanna M, Poldrugo F.

Minerva Psichiatr. 1981 Apr-Jun;22(2):85-92. Review. Italian. No abstract available.

PMID:
7022095
14.
15.

[Remarks on the action of Moditen-retard and Modecate. Apropos of 65 cases].

Scherrer P, Quiniou-Vidalenc.

Ann Med Psychol (Paris). 1976 Nov;2(4):642-56. French. No abstract available.

PMID:
1020862
16.

Clinical symptomatology and drug compliance in schizophrenic patients.

Bartkó G, Herczeg I, Zádor G.

Acta Psychiatr Scand. 1988 Jan;77(1):74-6.

PMID:
2894746
17.

[Folie à deux in schizophrenia--"psychogenesis" revisited].

Shimizu M.

Seishin Shinkeigaku Zasshi. 2004;106(5):546-63. Japanese.

PMID:
15230353
18.

Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.

Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, Hargreaves WA, Kane JM, Ninan PT, Frances A, Jacobs M, Lieberman JA, Mance R, Simpson GM, Woerner MG.

Arch Gen Psychiatry. 1997 May;54(5):453-63.

PMID:
9152099
19.

Supplemental Content

Support Center